Vectura is an emerging pharmaceutical company developing a range of inhaled drugs for the treatment of lung diseases and conditions where delivery via the lungs can provide significant benefits.

Vectura also actively licenses out its inhalation device and formulation technologies for product applications of other pharmaceutical companies and can provide pharmaceutical development support to its licensing partners and other long-term collaborators.